中國化學(601117.SH):子公司合計簽訂113億元項目框架協議
格隆匯1月10日丨中國化學(601117.SH)公佈,2020年1月9日,公司全資子公司中國五環工程有限公司(以下簡稱“五環公司”)、中化二建集團有限公司(以下簡稱“二公司”)、中國化學工程第六建設有限公司(以下簡稱“六公司”)與內蒙古博源控股集團有限公司(以下簡稱“博源集團”)分別簽署了《阿拉善塔木素天然鹼開發利用項目設計、採購及施工EPC/EP總承包框架協議》、《阿拉善塔木素天然鹼開發利用項目建築安裝總承包框架協議》和《阿拉善塔木素天然鹼開發利用項目建築安裝總承包框架協議》。
阿拉善塔木素天然鹼開發利用項目地點位於內蒙古自治區阿拉善盟阿拉善右旗塔木素布拉格蘇木,G7京新高速敖幹德力格收費站出口東南方向約25公里處。項目總合同價款暫定為113億元,其中五環公司的合同金額為68億元,二公司的合同金額為30億元,六公司的合同金額為15億元。
建設規模為年產780萬噸純鹼、80萬噸小蘇打及配套的公輔工程。工程內容是圍繞上述建設規模,總體產能按年產780萬噸純鹼、80萬噸小蘇打加工裝置配置,包括7條純鹼生產線、1條小蘇打生產線。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.